Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal ultra-low-dose naloxone for pain after lumbar laminectomy with fusion
IRCT20110614006803N11Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Intrathecal naloxone + morphine with Intrathecal morphine control (2 arms). Primary endpoint: Pain intensity. Started Aug 2015; status: completed.
02
Drugs
naloxonemorphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20110614006803N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110614006803N11.